154 related articles for article (PubMed ID: 7921716)
1. Alprazolam and exposure for panic disorder with agoraphobia. Attribution of improvement to medication predicts subsequent relapse.
Başoğlu M; Marks IM; Kiliç C; Brewin CR; Swinson RP
Br J Psychiatry; 1994 May; 164(5):652-9. PubMed ID: 7921716
[TBL] [Abstract][Full Text] [Related]
2. Relationship of panic, anticipatory anxiety, agoraphobia and global improvement in panic disorder with agoraphobia treated with alprazolam and exposure.
Başoğlu M; Marks IM; Kiliç C; Swinson RP; Noshirvani H; Kuch K; O'Sullivan G
Br J Psychiatry; 1994 May; 164(5):647-52. PubMed ID: 7921715
[TBL] [Abstract][Full Text] [Related]
3. Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto.
Marks IM; Swinson RP; Başoğlu M; Kuch K; Noshirvani H; O'Sullivan G; Lelliott PT; Kirby M; McNamee G; Sengun S
Br J Psychiatry; 1993 Jun; 162():776-87. PubMed ID: 8101126
[TBL] [Abstract][Full Text] [Related]
4. Pre-treatment predictors of treatment outcome in panic disorder and agoraphobia treated with alprazolam and exposure.
Başoğlu M; Marks IM; Swinson RP; Noshirvani H; O'Sullivan G; Kuch K
J Affect Disord; 1994 Feb; 30(2):123-32. PubMed ID: 7911132
[TBL] [Abstract][Full Text] [Related]
5. Comment on the London/Toronto Study of Alprazolam and Exposure in Panic Disorder with Agoraphobia.
Spiegel DA; Roth M; Weissman M; Lavori P; Gorman J; Rush J; Ballenger J
Br J Psychiatry; 1993 Jun; 162():788-9; discussion 790-4. PubMed ID: 8101127
[No Abstract] [Full Text] [Related]
6. Memory functions, alprazolam and exposure therapy: a controlled longitudinal study of agoraphobia with panic disorder.
Curran HV; Bond A; O'Sullivan G; Bruce M; Marks I; Lelliot P; Shine P; Lader M
Psychol Med; 1994 Nov; 24(4):969-76. PubMed ID: 7892364
[TBL] [Abstract][Full Text] [Related]
7. Panic disorder with agoraphobia.
Klein DF
Br J Psychiatry; 1993 Dec; 163():835-7. PubMed ID: 7905776
[No Abstract] [Full Text] [Related]
8. Safety and side-effects of alprazolam. Controlled study in agoraphobia with panic disorder.
O'Sullivan GH; Noshirvani H; Başoğlu M; Marks IM; Swinson R; Kuch K; Kirby M
Br J Psychiatry; 1994 Jul; 165(1):79-86. PubMed ID: 7802851
[TBL] [Abstract][Full Text] [Related]
9. Discontinuation reactions to alprazolam in panic disorder.
Pecknold JC
J Psychiatr Res; 1993; 27 Suppl 1():155-70. PubMed ID: 8145176
[TBL] [Abstract][Full Text] [Related]
10. Avoidance behaviour: a predictor of the efficacy of pharmacotherapy in panic disorder?
Maier W; Roth SM; Argyle N; Buller R; Lavori P; Brandon S; Benkert O
Eur Arch Psychiatry Clin Neurosci; 1991; 241(3):151-8. PubMed ID: 1790160
[TBL] [Abstract][Full Text] [Related]
11. A fixed-dose study of alprazolam 2 mg, alprazolam 6 mg, and placebo in panic disorder.
Lydiard RB; Lesser IM; Ballenger JC; Rubin RT; Laraia M; DuPont R
J Clin Psychopharmacol; 1992 Apr; 12(2):96-103. PubMed ID: 1573046
[TBL] [Abstract][Full Text] [Related]
12. Plasma alprazolam concentrations. Relation to efficacy and side effects in the treatment of panic disorder.
Greenblatt DJ; Harmatz JS; Shader RI
Arch Gen Psychiatry; 1993 Sep; 50(9):715-22. PubMed ID: 8357297
[TBL] [Abstract][Full Text] [Related]
13. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects.
Pecknold JC; Swinson RP; Kuch K; Lewis CP
Arch Gen Psychiatry; 1988 May; 45(5):429-36. PubMed ID: 3282479
[TBL] [Abstract][Full Text] [Related]
14. Agoraphobia and panic disorder: 3.5 years after alprazolam and/or exposure treatment.
Kiliç C; Noshirvani H; Başoğlu M; Marks I
Psychother Psychosom; 1997; 66(4):175-8. PubMed ID: 9259039
[TBL] [Abstract][Full Text] [Related]
15. Behavioural aggression in panic disorder after 8 weeks' treatment with alprazolam.
Bond AJ; Curran HV; Bruce MS; O'Sullivan G; Shine P
J Affect Disord; 1995 Dec; 35(3):117-23. PubMed ID: 8749839
[TBL] [Abstract][Full Text] [Related]
16. A controlled study of alprazolam and propranolol in panic-disordered and agoraphobic outpatients.
Ravaris CL; Friedman MJ; Hauri PJ; McHugo GJ
J Clin Psychopharmacol; 1991 Dec; 11(6):344-50. PubMed ID: 1770152
[TBL] [Abstract][Full Text] [Related]
17. Clinical and medication outcome after short-term alprazolam and behavioral group treatment in panic disorder. 2.5 year naturalistic follow-up study.
Nagy LM; Krystal JH; Woods SW; Charney DS
Arch Gen Psychiatry; 1989 Nov; 46(11):993-9. PubMed ID: 2818144
[TBL] [Abstract][Full Text] [Related]
18. Panic control treatment for agoraphobia.
Craske MG; DeCola JP; Sachs AD; Pontillo DC
J Anxiety Disord; 2003; 17(3):321-33. PubMed ID: 12727125
[TBL] [Abstract][Full Text] [Related]
19. Situational exposure treatment versus panic control treatment for agoraphobia. A case study.
Zarate R; Craske MG; Barlow DH
J Behav Ther Exp Psychiatry; 1990 Sep; 21(3):211-24. PubMed ID: 1982290
[TBL] [Abstract][Full Text] [Related]
20. Sequence of improvement in agoraphobia with panic attacks.
Rifkin A; Pecknold JC; Swinson RP; Ballenger JC; Burrows GD; Noyes R; Dupont RL; Lesser I
J Psychiatr Res; 1990; 24(1):1-8. PubMed ID: 2195163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
